Shenzhen New Industries Biomedical Engineering Co., Ltd. （Briefed as Snibe Co.,Ltd) is located in Hi-tech Industrial Park, Nanshan District of Shenzhen,founded in December 1995 with a registered capital of CNY 80,000,000. Snibe is a bio-medical company specialized in clinical laboratory instruments and in vitro diagnostic reagents. Snibe has formed a strong team of professionals: Reagents R & D and production center, Instruments R & D and production center, Sales & Marketing center.
Production of series of Nano Magnetic Microbeads products, mainly used for detection of soluble antigens, cell separation and gene isolation;
Production of Automated Chemiluminescence Immunoassay (CLIA) System –Maglumi 1000, Maglumi 2000, Maglumi 2000 PLUS analyzers and matched reagent kits;
Production of semi-auto Chemiluminescence Immunoassay (CLIA) System - Maglumi semi-auto chemiluminescence analyzers and matched reagent kits;
Production of magnetic enzyme immunoassay analyzer and matched reagent kits - Magimuzyme magnetic homogeneous enzyme immunoassay products.
Reagents R&D and production center is 3,000 square meters with 100,000 classes clean room, four reagent production lines, with annual production capacity of 500,000.00 boxes of reagent kit.
Instruments R&D and production center, is 6,000 square meters with annual production capacity of 1,500 units fully auto chemiluminescence immunoassay analyzers and 600 units semi-auto chemiluminescence immunoassay analyzers.
Sales & Marketing Center
Instruments Production Center
Reagents Production Center
Department of Reagent Quality Control
Snibe’s major shareholders: NII, Dr. Rao Wei, Sequoia Capital, Abax Global Capital.
NII, the dominant share holder, invested Snibe in 1995，is famous in the field of venture capital investment and investment bank , which has invested and managed a lot of companies in scope of optical electric, optical communication, medical technology, biological engineering, environmental protection and so forth, as well as securities, insurance, and trust service, experiences richly in capital investment and management.
Dr. Wei Rao, with Masters Degree in Materials Science from Beijing University of Aeronautic & Astronautic, and PHD Medical from Wuhan University of Technology, has been engaged in basic theories and engineering technique of organic-inorganic nano-composite material and its application in life science for a long time, presented at first new theory of synthesizing or ganic-monomer with inorganic nano particles worldwide by cooperation with his mentor, Professor Mr. Yuan Runzhang. Depending on it, Dr. Wei Rao invented the new material, the third generation nano-composite magnetic microbeads，which is certified State Invention Patent , and rewarded the third Prize in Hubei Province’s Scientific Progress. Dr. Wei Rao set up magnetic average phase enzyme immunoassay system and magnetic average phase chemo- luminescence immunoassay system by first application of nano-composite magnetic microbeads in 1990’s, and industrialized it.
Sequoia Capital, Abax Global Capital, these strategic investment from two well-known international investment institutions, have promoted the company's rapid growth, the company's technical superiority quickly into product advantages, further expanded domestic and foreign markets, enhancing our self-developed products competitiveness and market share.